Although MLK1 is tightly correlated with AR expression in a prostate cancer clinical dataset (Figure 1A), we found that the inhibitory effects of the MLK1 inhibitor NSC14465 applied to, not only AR-positive, but also AR-negative, cell lines (Figure 4B). The gene discussed is MAP3K9; the disease is prostate cancer.